Theranos Indirect Investors Denied Class Cert. For Fraud Suit
By Dunstan Prial · June 1, 2018, 6:17 PM EDT
A California federal judge on Thursday refused to certify a group of indirect investors alleging securities fraud claims against the once high-flying blood testing company Theranos Inc., finding that weaknesses in...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login